FDA Brief

Warning letters Animal

FDA warning letter to

Intermarket Industries Inc. dba Doc Ackerman Pet Products

High riskIssued Nov 12, 2024Posted Jan 7, 2025Center for Veterinary Medicine

FDA warns Doc Ackerman Pet Products that its Epilepsy & Seizure Formula for dogs and cats is an unapproved new animal drug.

What happened

FDA reviewed the firm’s Facebook account in October and November 2024 and reviewed third-party webpages. FDA found the firm directs customers to Doc Ackerman's Epilepsy & Seizure Formula on Amazon and Only Natural Pet Store and offers the product for sale there. FDA also found claims on labeling and webpages that the product treats epilepsy and seizures in dogs and cats.

What FDA found

  1. The product is a drug because its name, labeling, and promotional claims say it treats epilepsy and seizures in animals and affects the body.

    FD&C Act section 201(g)(1) [21 U.S.C. 321(g)(1)]
  2. It is a new animal drug because it is not generally recognized by qualified experts as safe and effective for the labeled uses.

    FD&C Act section 201(v) [21 U.S.C. 321(v)]
  3. It has no approved new animal drug application, conditional approval, or index listing, so FDA considers it unsafe and adulterated.

    FD&C Act sections 512(a) and 501(a)(5) [21 U.S.C. 360b(a), 351(a)(5)]
  4. The firm introduces or delivers the product into interstate commerce, which the FD&C Act prohibits for this product.

    FD&C Act section 301(a) [21 U.S.C. 331(a)]

What FDA wants

Within 15 working days of receipt, notify FDA’s Center for Veterinary Medicine in writing of the specific steps taken to address the violations, explain how recurrence will be prevented, and include related documentation. If corrective action cannot be completed in that time, state the reason and when it will be completed.

Who should pay attention

  • pet owners who buy seizure remedies online
  • retailers and online marketplaces selling pet remedies
  • makers of herbal pet products with disease-treatment claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. AHC Products, Inc.

    AHC Products, Inc. was cited for manufacturing-rule violations and unapproved animal drugs, including AniPrin and Rot-B-Gone.

    High risk
  2. The Fish Aid

    FDA warned The Fish Aid it sells unapproved, unlisted antibiotics for aquarium fish and birds without veterinary oversight.

    High risk
  3. DK Hardware Supply

    FDA warns DK Hardware Supply over unapproved, unlisted aquarium-fish antibiotic drugs.

    High risk
  4. Synergy Animal Products, Inc.

    Synergy Animal Products marketed unapproved animal drugs for dairy cows with inadequate directions and major manufacturing violations.

    High risk